Seller record · Telehealth service

Luma Health Co.

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named on the pricing page, the weight loss page, the answers, the terms or the privacy notice. 2 more criteria also fail; see the table below.

At a glance

Luma Health Co.Telehealth service

5/8criteria passed

Price: Semaglutide from $115 for 4 weeks, tirzepatide from $180
Sells: semaglutide, tirzepatide, NAD+, and 1 more
FDA letters: None on file

Visit Luma Health Co.See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A Louisiana-based virtual clinic led by a family nurse practitioner and serving 30 states and Washington, DC, selling semaglutide and tirzepatide priced by dose for a 4-week supply, and NAD+ and B12 injections. Care starts with a scheduled consultation, and no pharmacy is named.

Operating entity No legal entity name appears in the footer, on the contact page, in the terms, in the privacy notice or in the telehealth consent, which use only the trade name.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Luma Health Co.'s website
S2	Prescription gating	PASS	Luma Health Co.'s website; Luma Health Co.'s contact page
S3	Pharmacy identification	FAIL	Luma Health Co.'s services page; Luma Health Co.'s blank page; Luma Health Co.'s contact page
S4	Compounding disclosure	FAIL	Luma Health Co.'s services page; Luma Health Co.'s blank page; Luma Health Co.'s website
S5	Analytical documentation	FAIL	Luma Health Co.'s services page; Luma Health Co.'s blank page; Luma Health Co.'s contact page
S6	Business address	PASS	Luma Health Co.'s website; Luma Health Co.'s contact page
S7	Price disclosure	PASS	Luma Health Co.'s services page; Luma Health Co.'s contact page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSThe about page names the founder, a family nurse practitioner who leads clinical operations, and the telehealth consent names her as the treating provider with her Louisiana license number. The steps say each plan is built from the patient's goals, labs and health history.Source: Luma Health Co.'s website.

S2PASSEvery start button opens a scheduling page for a consultation, and the steps put the consultation before the plan and the treatment; the answers say treatment can begin a few business days after the initial consultation.Source: Luma Health Co.'s website; Luma Health Co.'s contact page.

S3FAILNo filling pharmacy is named on the pricing page, the weight loss page, the answers, the terms or the privacy notice.Source: Luma Health Co.'s services page; Luma Health Co.'s blank page; Luma Health Co.'s contact page.

S4FAILThe pricing page lists semaglutide and tirzepatide by 4-week supply at $115 to $275 without saying whether they are compounded, and no page, including the terms, the privacy notice and the telehealth consent, states that compounded medications are not FDA-approved.Source: Luma Health Co.'s services page; Luma Health Co.'s blank page; Luma Health Co.'s website.

S5FAILNo certificate of analysis or lot document is published on the pricing page, the weight loss page or the answers.Source: Luma Health Co.'s services page; Luma Health Co.'s blank page; Luma Health Co.'s contact page.

S6PASS29728 S Frost Rd, #1056, Livingston, LA 70754, printed in the footer of every page and on the contact page. The terms name Louisiana law.Source: Luma Health Co.'s website; Luma Health Co.'s contact page.

S7PASSSemaglutide from $115 for a 4-week supply at 0.25 mg to $185 at 2.5 mg, and tirzepatide from $180 at 2.5 mg to $275 at 15 mg. NAD+ at $175 for a 10-week supply and B12 injections at $100 for 20 weeks. The pricing page offers a free first consultation through September, and the answers say there is no subscription or monthly fee.Source: Luma Health Co.'s services page; Luma Health Co.'s contact page.

S8PASSNo FDA warning letter names Luma Health Co., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: semaglutide, tirzepatide, NAD+, methylcobalamin (B12) injections.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells NAD+

Visit Luma Health Co.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.